Amyotrophic lateral sclerosis in Antalya, Turkey. A prospective study, 2016–2018

References

• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–E24.
   PubMed Web of Science ®Google Scholar
• Kumar RD, Aslinia F, Yale SH, Mazza JJ. Jean-Martin Charcot: the father of neurology. Clin Med Res. 2011;4:46–9.
   Google Scholar
• Benjaminsen E, Alstadhaug KB, Gulsvik M, Baloch FK, Odeh F. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000–2015: prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:522–7.
   PubMed Web of Science ®Google Scholar
• Jun KY, Park J, Oh KW, Kim EM, Bae JS, Kim I, et al. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry. 2019;90:395–403.
   PubMed Web of Science ®Google Scholar
• Leighton DJ, Newton J, Stephenson LJ, Colville S, Davenport R, Gorrie G, CARE-MND Consortium, et al. Changing epidemiology of motor neurone disease in Scotland. J Neurol. 2019;266:817–25.
   PubMed Web of Science ®Google Scholar
• Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771–6.
   PubMed Web of Science ®Google Scholar
• Longinetti E, Wallin AR, Samuelsson K, Press R, Zachau A, Ronnevi LO, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:528–37.
   PubMed Web of Science ®Google Scholar
• Palese F, Sartori A, Verriello L, Ros S, Passadore P, Manganotti P, et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002–2014: a retrospective population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:90–9.
   PubMed Web of Science ®Google Scholar
• Rose L, McKim D, Leasa D, Nonoyama M, Tandon A, Bai YQ, et al. Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: a population-based retrospective cohort study (2003–2014). PLoS One. 2019;14:e0210574.
   PubMed Web of Science ®Google Scholar
• Turgut N, Saracoglu GV, Kat S, Balci K, Guldiken B, Birgili O, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006–2010. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:100–6.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52:93–103.
   PubMed Web of Science ®Google Scholar
• Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
   PubMed Web of Science ®Google Scholar
• Nelson LM, Topol B, Kaye W, Williamson D, Horton DK, Mehta P, et al. Estimation of the prevalence of amyotrophic lateral sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and capture-recapture methodology. Neuroepidemiology. 2018;51:149–57.
   PubMed Web of Science ®Google Scholar
• Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996;15:239–45.
   PubMed Web of Science ®Google Scholar
• Kihira T, Yoshida S, Hironishi M, Miwa H, Okamato K, Kondo T. Changes in the incidence of amyotrophic lateral sclerosis in Wakayama, Japan. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:155–63.
   PubMed Web of Science ®Google Scholar
• Bhattacharya R, Harvey RA, Abraham K, Rosen J, Mehta P. Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:251–9.
   PubMed Web of Science ®Google Scholar
• De Marchi F, Sarnelli MF, Solara V, Bersano E, Cantello R, Mazzini L. Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand. 2019;139:438–45.
   PubMed Web of Science ®Google Scholar
• Dickerson AS, Hansen J, Kioumourtzoglou MA, Specht AJ, Gredal O, Weisskopf MG. Study of occupation and amyotrophic lateral sclerosis in a Danish cohort. Occup Environ Med. 2018;75:630–8.
   PubMed Web of Science ®Google Scholar
• Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hubers A, Schuster J, et al. Prognostic factors in ALS: a comparison between Germany and China. J Neurol. 2019;266:1516–25.
   PubMed Web of Science ®Google Scholar
• Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–92.
   PubMed Web of Science ®Google Scholar
• Goutman SA, Boss J, Patterson A, Mukherjee B, Batterman S, Feldman EL. High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:907–12.
   PubMed Web of Science ®Google Scholar
• Hodgkinson VL, Lounsberry J, Mirian A, Genge A, Benstead T, Briemberg H, et al. Provincial differences in the diagnosis and care of amyotrophic lateral sclerosis. Can J Neurol Sci. 2018;45:652–9.
   PubMed Web of Science ®Google Scholar
• Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90:666–73.
   PubMed Web of Science ®Google Scholar
• Ryan M, Vaillant TZ, McLaughlin RL, Doherty MA, Rooney J, Heverin M, et al. Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations. J Neurol Neurosurg Psychiatry. 2019;90:659–65.
   PubMed Web of Science ®Google Scholar
• Luna J, Diagana M, Aissa LA, Tazir M, Pacha LA, Kacem I, et al. Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study. J Neurol Neurosurg Psychiatry. 2019;90:20–9.
   PubMed Web of Science ®Google Scholar
• Pupillo E, Bianchi E, Chio A, Casale F, Zecca C, Tortelli R, SLAP Group, et al. Amyotrophic lateral sclerosis and food intake. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:267–74.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Nakayama Y, Matsuda C, Haraguchi M, Bokuda K, Ishikawa-Takata K, et al. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol. 2019;266:1412–20.
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Swingler RJ, Scottish A, Scottish ALS/MND Register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing. 2004;33:131–4.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Naturel history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19.
   PubMed Web of Science ®Google Scholar
• Qadri S, Langefeld CD, Milligan C, Caress JB, Cartwright MS. Racial differences in intervention rates in individuals with ALS: a case–control study. Neurology. 2019;92:e1969–E74.
   PubMed Web of Science ®Google Scholar
• Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron M-C, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229–45.
   PubMed Web of Science ®Google Scholar
• Institute TS. Population statistics and population projections. 2016.
   Google Scholar
• De Carvalho M, Ryczkowski A, Andersen P, Gromicho M, Grosskreutz J, Kuzma-Kozakiewicz M, et al. International survey of ALS experts about critical questions for assessing patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:505–10.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, Gr WFNR, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Koc F, Balal M, Demir T, Alparslan ZN, Sarica Y. Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R). Noro Psikiyatr Ars. 2016;53:229–33.
   PubMedGoogle Scholar
• Bureau USC. Mid-year five year age groups and sex – custom region – United States. Washington, DC: US Department of Commerce, US Census Bureau; 2016.
   Google Scholar